Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Tetraphase Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Tetraphase Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Tetraphase Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Tetraphase Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Tetraphase Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Tetraphase Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Tetraphase Pharma Raises Funds Through Venture Financing 11
Licensing Agreements 12
Everest Medicines Enters into Licensing Agreement with Tetraphase Pharma 12
Equity Offering 13
Tetraphase Pharma Plans to Raise up to USD150 Million in Public Offering of Shares 13
Tetraphase Pharma Raises USD65 Million in Public Offering of Shares 14
Tetraphase Pharmaceuticals Raises USD7.6 Million in Public Offering of Common Stock 16
Tetraphase Pharma Raises USD5.6 Million in Public Offering of Shares 17
Tetraphase Pharma Increase its Size of Public Offering of Shares for USD80 Million 19
Tetraphase Pharma Raises USD173 Million in Public Offering of Shares 20
Tetraphase Pharma Raises USD86.3 Million in Public Offering of Shares 22
Tetraphase Pharma Completes Underwriters’ Exercise Of Partial Over-Allotment Option Of Public Offering Of Shares For US$49 Million 24
Tetraphase Pharma Announces That Underwriters’ Of Its IPO Exercise Their Over-Allotment Option 26
Acquisition 28
Tetraphase Pharma May Sell Itself 28
Tetraphase Pharmaceuticals Inc – Key Competitors 30
Tetraphase Pharmaceuticals Inc – Key Employees 31
Tetraphase Pharmaceuticals Inc – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 33
Financial Announcements 33
Aug 02, 2018: Tetraphase Pharmaceuticals reports second quarter 2018 financial results and recent highlights 33
May 03, 2018: Tetraphase Pharmaceuticals Reports First Quarter 2018 Financial Results and Recent Highlights 35
Mar 06, 2018: Tetraphase Pharmaceuticals Reports Fourth Quarter and Full-Year 2017 Financial Results, Highlights Achievements and Key 2018 Milestones 37
Nov 02, 2017: Tetraphase Pharmaceuticals Reports Third Quarter 2017 Financial Results and Highlights Recent Clinical and Corporate Achievements 39
Aug 02, 2017: Tetraphase Pharmaceuticals Reports Second Quarter 2017 Financial Results 41
Aug 02, 2017: Tetraphase Q2 net loss up 42
May 04, 2017: Tetraphase Pharmaceuticals Reports First Quarter 2017 Financial Results and Reviews Recent Highlights 43
Mar 08, 2017: Tetraphase Pharmaceuticals Reports Fourth Quarter and Full-Year 2016 Financial Results and Highlights Key 2017 Milestones 44
Corporate Communications 46
Mar 01, 2018: Tetraphase Pharmaceuticals Appoints Larry Edwards Chief Operating Officer 46
Oct 16, 2017: Tetraphase Pharmaceuticals Appoints Kam Unninayar as Chief Financial Officer 47
Other Significant Developments 48
Aug 27, 2018: Tetraphase Pharmaceuticals to participate at upcoming investor conferences 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49
Tetraphase Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Tetraphase Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Tetraphase Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Tetraphase Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Tetraphase Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Tetraphase Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Tetraphase Pharma Raises Funds Through Venture Financing 11
Everest Medicines Enters into Licensing Agreement with Tetraphase Pharma 12
Tetraphase Pharma Plans to Raise up to USD150 Million in Public Offering of Shares 13
Tetraphase Pharma Raises USD65 Million in Public Offering of Shares 14
Tetraphase Pharmaceuticals Raises USD7.6 Million in Public Offering of Common Stock 16
Tetraphase Pharma Raises USD5.6 Million in Public Offering of Shares 17
Tetraphase Pharma Increase its Size of Public Offering of Shares for USD80 Million 19
Tetraphase Pharma Raises USD173 Million in Public Offering of Shares 20
Tetraphase Pharma Raises USD86.3 Million in Public Offering of Shares 22
Tetraphase Pharma Completes Underwriters’ Exercise Of Partial Over-Allotment Option Of Public Offering Of Shares For US$49 Million 24
Tetraphase Pharma Announces That Underwriters' Of Its IPO Exercise Their Over-Allotment Option 26
Tetraphase Pharma May Sell Itself 28
Tetraphase Pharmaceuticals Inc, Key Competitors 30
Tetraphase Pharmaceuticals Inc, Key Employees 31
Tetraphase Pharmaceuticals Inc, Subsidiaries 32
List of Figures
Tetraphase Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Tetraphase Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Tetraphase Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Tetraphase Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Tetraphase Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Tetraphase Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Tetraphase Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Tetraphase Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9